Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.
2.

Factors derived from Escherichia coli Nissle 1917, grown in different growth media, enhance cell death in a model of 5-fluorouracil-induced Caco-2 intestinal epithelial cell damage.

Wang H, Bastian SE, Lawrence A, Howarth GS.

Nutr Cancer. 2015;67(2):316-26. doi: 10.1080/01635581.2015.990570. Epub 2015 Jan 27.

PMID:
25625670
3.

Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage.

Prisciandaro LD, Geier MS, Chua AE, Butler RN, Cummins AG, Sander GR, Howarth GS.

Support Care Cancer. 2012 Dec;20(12):3205-10. doi: 10.1007/s00520-012-1446-3. Epub 2012 Apr 20.

PMID:
22526145
4.

Effects of Supernatants from Escherichia coli Nissle 1917 and Faecalibacterium prausnitzii on Intestinal Epithelial Cells and a Rat Model of 5-Fluorouracil-Induced Mucositis.

Wang H, Jatmiko YD, Bastian SE, Mashtoub S, Howarth GS.

Nutr Cancer. 2017 Feb-Mar;69(2):307-318. doi: 10.1080/01635581.2017.1263747. Epub 2017 Jan 17.

PMID:
28094590
5.

Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis.

Cheah KY, Howarth GS, Yazbeck R, Wright TH, Whitford EJ, Payne C, Butler RN, Bastian SE.

Cancer Biol Ther. 2009 Feb;8(4):382-90. Epub 2009 Feb 18.

PMID:
19305141
6.

Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats.

Prisciandaro LD, Geier MS, Butler RN, Cummins AG, Howarth GS.

Cancer Biol Ther. 2011 Apr 1;11(7):671-7. Epub 2011 Apr 1.

PMID:
21307648
7.

Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracil.

Gao J, Gao J, Qian L, Wang X, Wu M, Zhang Y, Ye H, Zhu S, Yu Y, Han W.

Cancer Biol Ther. 2014 Aug;15(8):982-91. doi: 10.4161/cbt.29114. Epub 2014 May 6.

8.

Alanyl-glutamine and glutamine supplementation improves 5-fluorouracil-induced intestinal epithelium damage in vitro.

Braga-Neto MB, Warren CA, Oriá RB, Monteiro MS, Maciel AA, Brito GA, Lima AA, Guerrant RL.

Dig Dis Sci. 2008 Oct;53(10):2687-96. doi: 10.1007/s10620-008-0215-0. Epub 2008 Mar 6.

9.

Interleukin-1 receptor antagonist reduced apoptosis and attenuated intestinal mucositis in a 5-fluorouracil chemotherapy model in mice.

Wu ZQ, Han XD, Wang Y, Yuan KL, Jin ZM, Di JZ, Yan J, Pan Y, Zhang P, Huang XY, Wang ZG, Zheng Q.

Cancer Chemother Pharmacol. 2011 Jul;68(1):87-96. doi: 10.1007/s00280-010-1451-5. Epub 2010 Sep 16.

PMID:
20844880
10.

The effect of probiotic Escherichia coli strain Nissle 1917 lipopolysaccharide on the 5-aminosalicylic acid transepithelial transport across Caco-2 cell monolayers.

Stětinová V, Smetanová L, Kholová D, Květina J, Svoboda Z, Zídek Z, Tlaskalová-Hogenová H.

Gen Physiol Biophys. 2013 Sep;32(3):371-80. doi: 10.4149/gpb_2013035. Epub 2013 Jul 12.

PMID:
23846256
11.

Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis.

Azevedo OG, Oliveira RA, Oliveira BC, Zaja-Milatovic S, Araújo CV, Wong DV, Costa TB, Lucena HB, Lima RC Jr, Ribeiro RA, Warren CA, Lima AÂ, Vitek MP, Guerrant RL, Oriá RB.

BMC Gastroenterol. 2012 Jul 13;12:35. doi: 10.1186/1471-230X-12-35.

12.

Stimulation of intestinal epithelial restitution by prostaglandin E(1) analogue.

Hirata K, Horie T.

Cancer Chemother Pharmacol. 2003 Mar;51(3):216-20. Epub 2003 Feb 26.

PMID:
12655439
13.

5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells.

Yasuda M, Kato S, Yamanaka N, Iimori M, Matsumoto K, Utsumi D, Kitahara Y, Amagase K, Horie S, Takeuchi K.

Br J Pharmacol. 2013 Mar;168(6):1388-400. doi: 10.1111/bph.12019.

14.

Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats.

Cool JC, Dyer JL, Xian CJ, Butler RN, Geier MS, Howarth GS.

Growth Horm IGF Res. 2005 Feb;15(1):72-82. Epub 2005 Jan 21.

PMID:
15701575
15.

Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair.

Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA.

Cell Microbiol. 2007 Mar;9(3):804-16. Epub 2006 Nov 3.

PMID:
17087734
16.

Dietary supplementation with omega-3 fatty acid attenuates 5-fluorouracil induced mucositis in mice.

Generoso Sde V, Rodrigues NM, Trindade LM, Paiva NC, Cardoso VN, Carneiro CM, Ferreira AV, Faria AM, Maioli TU.

Lipids Health Dis. 2015 Jun 12;14:54. doi: 10.1186/s12944-015-0052-z.

17.

Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.

Yasuda M, Kato S, Yamanaka N, Iimori M, Utsumi D, Kitahara Y, Iwata K, Matsuno K, Amagase K, Yabe-Nishimura C, Takeuchi K.

Am J Physiol Gastrointest Liver Physiol. 2012 May 15;302(10):G1133-42. doi: 10.1152/ajpgi.00535.2011. Epub 2012 Mar 8.

18.

In vitro and in vivo uptake study of Escherichia coli Nissle 1917 bacterial ghosts: cell-based delivery system to target ocular surface diseases.

Stein E, Inic-Kanada A, Belij S, Montanaro J, Bintner N, Schlacher S, Mayr UB, Lubitz W, Stojanovic M, Najdenski H, Barisani-Asenbauer T.

Invest Ophthalmol Vis Sci. 2013 Sep 24;54(9):6326-33. doi: 10.1167/iovs.13-12044.

PMID:
23920373
19.

Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4.

Soares PM, Mota JM, Souza EP, Justino PF, Franco AX, Cunha FQ, Ribeiro RA, Souza MH.

Cytokine. 2013 Jan;61(1):46-9. doi: 10.1016/j.cyto.2012.10.003. Epub 2012 Oct 26.

20.

Lutein protects against methotrexate-induced and reactive oxygen species-mediated apoptotic cell injury of IEC-6 cells.

Chang CJ, Lin JF, Chang HH, Lee GA, Hung CF.

PLoS One. 2013 Sep 6;8(9):e72553. doi: 10.1371/journal.pone.0072553. eCollection 2013.

Supplemental Content

Support Center